Ann: Monash IVF Group 1H18 Results Presentation, page-35

First 35 Last

Share
Profile

Follow
PhoenixAM2017

493 Posts.

18

24/03/18

21:11

Post #: 32002732
Share

Originally posted by Just_a_guy ↑

Bought back in yesterday. I was hoping we might get down here but thought it might take the next set of results.

Havoc? Obviously the share price has taken a big hit which I think is namely due to two factors. Firstly the push for bulk billing services, and also from losing their top billing doctor. But why do you say havoc?
I’m not sure about the internal culture and whether this played a significant role in LB leaving but obviously there are some questions about that side of things, but that probably came from the top and I expect the new ceo, to address these issues. Personally I wasn’t a fan of JT anyway so hopefully the new md is an improvement. Given the need for advertising and the power of scale in this field, I think it’s very hard for ivf doctors (particularly young ones) to go it alone unlike surgeons and most physicians.
I don’t think mvf have anything to worry about with respect to their debt. 94mil with ebitda this year probably coming in at 40-43mil. Low capital costs. So I don’t see how the share price can drop much further below the intrinsic value of the business despite the expectation of average results over the next 6-12months. Having said that, I’d be more than happy if it did as I’ll add to my holding.

Currently trading a tad over 8x ev/ebitda. I expect the dividend to be another 3-3.3c at the end of the year despite significant one offs (ceo recruitment and LB legal costs) making a dividend yield of about 6.6cents (12.6c eps last year - 25% x payout ratio of 65-70%) giving a fully franked dividend yield of >6% despite a modest payout ratio. Fcf yield is even higher.

The market may be expecting further profit loss in fy19, but I think we’ll revert to growth in fy19. I think cycles should at least stabilise, and both diagnostics and Malaysia should keep improving.

Takeover is my only ‘worry’

Expand

When the overall market is in a downward trend, very likely the price will go down even further to $1.00 mark, which will be a good entry point providing some margin of safety...

MVF Price at posting: $1.09 Sentiment: Hold Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

STP

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

There are more pages in this discussion • 4 more messages in this thread...

First 35 Last

Add MVF (ASX) to my watchlist

(20min delay)
Last $1.16		Change 0.040(3.59%)		Mkt cap ! $465.6M

Open	High	Low	Value	Volume
$1.12	$1.16	$1.11	$1.112M	991.6K

Buyers (Bids)

No.	Vol.	Price($)
2	323	$1.21

Sellers (Offers)

Price($)	Vol.	No.
$1.05	1587	1

View Market Depth

No.	Vol.	Price($)
1	489	1.185
2	13458	1.180
2	8045	1.175
3	33465	1.170
3	3838	1.165

Price($)	Vol.	No.
1.195	5821	3
1.200	20501	4
1.205	4251	3
1.210	3037	1
1.215	3037	1

Last trade - 15.59pm 19/11/2024 (20 minute delay)

MVF (ASX) Chart

Ann: Monash IVF Group 1H18 Results Presentation, page-35

Top Stories

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

Buyers (Bids)

Sellers (Offers)